Cargando…

Androgen deprivation therapy promotes an obesity-like microenvironment in periprostatic fat

Prostate cancer is a leading cause of morbidity and cancer-related death worldwide. Androgen deprivation therapy (ADT) is the cornerstone of management for advanced disease. The use of these therapies is associated with multiple side effects, including metabolic syndrome and truncal obesity. At the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mangiola, Stefano, Stuchbery, Ryan, McCoy, Patrick, Chow, Ken, Kurganovs, Natalie, Kerger, Michael, Papenfuss, Anthony, Hovens, Christopher M, Corcoran, Niall M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499921/ https://www.ncbi.nlm.nih.gov/pubmed/30959474 http://dx.doi.org/10.1530/EC-19-0029

Ejemplares similares

Loss of SNAI2 in Prostate Cancer Correlates With Clinical Response to Androgen Deprivation Therapy
por: Cmero, Marek, et al.
Publicado: (2021)

Transcriptome sequencing and multi-plex imaging of prostate cancer microenvironment reveals a dominant role for monocytic cells in progression
por: Mangiola, Stefano, et al.
Publicado: (2021)

Biomarkers of Response to Neoadjuvant Androgen Deprivation in Localised Prostate Cancer
por: Pechlivanis, Maree, et al.
Publicado: (2021)

Comparing nodal versus bony metastatic spread using tumour phylogenies
por: Mangiola, Stefano, et al.
Publicado: (2016)

Detection of ctDNA in plasma of patients with clinically localised prostate cancer is associated with rapid disease progression
por: Lau, Edmund, et al.
Publicado: (2020)

Periprostatic venous thrombosis
por: Paulino, Eduardo, et al.
Publicado: (2016)

Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer
por: Soekmadji, Carolina, et al.
Publicado: (2016)

Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progression
por: Stuchbery, Ryan, et al.
Publicado: (2016)

Preparation of fluorescent in situ hybridisation probes without the need for optimisation of fragmentation
por: McCoy, Patrick J., et al.
Publicado: (2018)

Periprostatic fat measured on computed tomography as a marker for prostate cancer aggressiveness
por: van Roermund, Joep G. H., et al.
Publicado: (2009)

Periprostatic Adipose Tissue Microenvironment: Metabolic and Hormonal Pathways During Prostate Cancer Progression
por: Sacca, Paula Alejandra, et al.
Publicado: (2022)

Influence of body mass index and periprostatic fat on rectal dosimetry in permanent seed prostate brachytherapy
por: Tiberi, David, et al.
Publicado: (2014)

Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer
por: Hong, Matthew K.H., et al.
Publicado: (2015)

Periprostatic Perineurioma, Description of a Case With Unusual Localization
por: Guerriero, Massimiliano, et al.
Publicado: (2016)

Inferring structural variant cancer cell fraction
por: Cmero, Marek, et al.
Publicado: (2020)

Author Correction: Inferring structural variant cancer cell fraction
por: Cmero, Marek, et al.
Publicado: (2022)

The lipidomic profile of the tumoral periprostatic adipose tissue reveals alterations in tumor cell’s metabolic crosstalk
por: Altuna-Coy, Antonio, et al.
Publicado: (2022)

Interfacing Seurat with the R tidy universe
por: Mangiola, Stefano, et al.
Publicado: (2021)

Periprostatic adipose inflammation is associated with high-grade prostate cancer
por: Gucalp, Ayca, et al.
Publicado: (2017)

Incidental periprostatic schwannoma discovered during evaluation for prostatic adenocarcinoma
por: Dietrick, Barbara, et al.
Publicado: (2020)

Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy
por: Stensland, Kristian D, et al.
Publicado: (2022)

Periprostatic fat thickness measured on MRI correlates with lower urinary tract symptoms, erectile function, and benign prostatic hyperplasia progression
por: Zhang, Bo, et al.
Publicado: (2020)

Human periprostatic adipose tissue promotes prostate cancer aggressiveness in vitro
por: Ribeiro, Ricardo, et al.
Publicado: (2012)

Neuroanatomical Study of Periprostatic Nerve Distributions Using Human Cadaver Prostate
por: Sung, Wooseuk, et al.
Publicado: (2010)

Hypertension secondary to a periprostatic paraganglioma: case report and review of the literature
por: Kers, Jesper, et al.
Publicado: (2013)

Myeloid sarcoma of the periprostatic tissue and prostate: Case report and review of literature
por: Koppisetty, Shalini, et al.
Publicado: (2016)

The Role of Periprostatic Adipose Tissue on Prostate Function in Vascular-Related Disorders
por: Passos, Gabriela Reolon, et al.
Publicado: (2021)

The distribution pattern of periprostatic neurovascular bundles examined with successive celloidin slices
por: Li, Xuemei, et al.
Publicado: (2021)

A Case of Traumatic Catheterisation leading to Rectal Perforation and Periprostatic Abscess
por: Cullivan, Orla, et al.
Publicado: (2022)

The effect of continuous androgen deprivation treatment on prostate cancer patients as compared with intermittent androgen deprivation treatment
por: Ku, Ja Yoon, et al.
Publicado: (2015)

Engineering osteoblastic metastases to delineate the adaptive response of androgen-deprived prostate cancer in the bone metastatic microenvironment
por: Bock, Nathalie, et al.
Publicado: (2019)

Normalized periprostatic fat MRI measurements can predict prostate cancer aggressiveness in men undergoing radical prostatectomy for clinically localised disease
por: Dahran, Naief, et al.
Publicado: (2017)

The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer
por: Shaw, Greg L., et al.
Publicado: (2016)

Androgen deprivation and cognition in prostate cancer
por: Salminen, E, et al.
Publicado: (2003)

Androgen Deprivation Therapy and Cardiovascular Risk
por: Mourmouris, Panagiotis, et al.
Publicado: (2012)

Metabolic effects of androgen deprivation therapy
por: Choi, See Min, et al.
Publicado: (2015)

Cardiovascular Toxicities of Androgen Deprivation Therapy
por: Challa, Azariyas A., et al.
Publicado: (2021)

CARDIOVASCULAR DISEASES AND ANDROGEN DEPRIVATION THERAPY
por: Boban, Marko
Publicado: (2019)

Cardiovascular Toxicity of Androgen Deprivation Therapy
por: Boland, Julia, et al.
Publicado: (2021)

Obesity and prostate cancer: gene expression signature of human periprostatic adipose tissue
por: Ribeiro, Ricardo, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_2sokbgrdd2497mf3m33sp26nhc